First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors.

NCT06240546 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: LPM6690176

Sponsor

Luye Pharma Group Ltd.